Search Report
Home   About Us   Press Room   Custom Research   Research Store   Contact Us
Press Releases

 

Rising Production Cost Concerns to Boost Biopharmaceutical Contract Manufacturing Market

Jan 19, 2011
Share |
 
According to our latest research offering Global Contract Manufacturing Market Analysis, the biopharmaceutical industry is witnessing stupendous growth after recovering from the aftermath of the global recession. However, a major concern for the industry has been the high cost of production incurred, which deeply affects the earning capacity of the companies. To minimize the costs, companies are looking to outsource the production work to establishments in the emerging nations. Through this, Biopharma giants aim at acquiring services like, pre-clinical development, active manufacturing, commercial batch manufacturing, packaging, and other related services. Hence, it is expected that the global contract manufacturing industry will experience growth at a CAGR of around 12% during 2010-2012.
 
The report depicts the overall market scenario in the prominent destinations of the developed and developing regions. Apart from the current market scenario in these destinations, the report covers the key players operating and the future direction of the industry. A prudent analysis of the past and current trends in the local market delineates the favorable locations for the purpose of contract manufacturing.
 
Our report “Global Contract Manufacturing Market Analysis” also covers the various key market trends and a detail competitive landscape of the industry. Besides, the report comprehensively discusses various issues being faced by the industry, including IP issues, investment risks, and issues related to quality assurance. These segments are aimed at providing a pragmatic outlook of the contract manufacturing market, thereby allowing the identification of the shortcomings of certain avenues in the industry.
 
Analysis of the ongoing developments, market expectations, and driving factors facilitates clear market intelligence. Apart from the current market scenario, forecasts included in the report provides a clear picture of the future scenario of the industry. The report would help clients in enhancing their understanding regarding the industry and thereby, formulating strategies to help their business growth.

For more information visit: http://www.rncos.com/Report/IM265.htm

Related Press Releases:
» US Generic Drugs to Grow Strongly in Future
» FDI Fuelling Growth of Hospital Services in India
» Indian Diagnostic Market Poised to Grow at 16% CAGR
» Next-Generation Sequencing Market to Touch US$ 2 Billion-Mark by 2015
» European Regenerative Medicine Market worth US$ 2.2 Billion in 2010
 
Related Research Reports
Related Research News
May 03, 2010
New Product Launches Led US Pharma Market to Grow Strongly in 2009
Apr 30, 2010
India to be Among Top 10 Drug Producers by 2020
Apr 05, 2010
China ? On the Way to Become Third Largest Pharma Market
Jan 25, 2010
Indian Government to Set Up Special Zones to Boost Pharma Exports
Phone : +91 (120) 4224700/01/02/03
Fax : +91 (120) 4224707

Copyright © 2011, RNCOS, 2002-2011

Home
About Us
Careers
Request a Quote
Discounted Reports
Contact Us
Add URL
FAQ
Upcoming Reports